BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26683340)

  • 1. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
    Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
    Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
    Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
    Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.
    Luo YD; Fang L; Yu HQ; Zhang J; Lin XT; Liu XY; Wu D; Li GX; Huang D; Zhang YJ; Chen S; Jiang Y; Shuai L; He Y; Zhang LD; Bie P; Xie CM
    J Hepatol; 2021 Jan; 74(1):96-108. PubMed ID: 32738450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.
    Diegel CR; Cho KR; El-Naggar AK; Williams BO; Lindvall C
    Cancer Res; 2010 Nov; 70(22):9143-52. PubMed ID: 21062985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
    Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
    Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
    Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of p21 and nuclear accumulation of TAp73alpha and c-abl during apoptosis of cisplatin-treated primary pancreatic acinar cells.
    Sphyris N; Morris RG; Harrison DJ
    Int J Oncol; 2004 Dec; 25(6):1661-70. PubMed ID: 15547703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
    Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
    Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK.
    Wu H; He D; Biswas S; Shafiquzzaman M; Zhou X; Charron J; Wang Y; Nayak BK; Habib SL; Liu H; Li B
    Cancer Res; 2021 Jun; 81(12):3174-3186. PubMed ID: 33863779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging.
    Zhang N; Lyons S; Lim E; Lassota P
    Clin Cancer Res; 2009 Aug; 15(15):4915-24. PubMed ID: 19622581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch.
    Xiang X; Lan H; Tang H; Yuan F; Xu Y; Zhao J; Li Y; Zhang W
    Diabetes; 2015 Feb; 64(2):519-28. PubMed ID: 25213336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.